

[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI

[ Wed, Jan 04th 2023
] - WOPRAI
[ Wed, Jan 04th 2023
] - WOPRAI
[ Wed, Jan 04th 2023
] - WOPRAI
Yanan Zhu Maintained (TSHA) at Buy with Decreased Target to $10 on, Jan 4th, 2023
Yanan Zhu of Wells Fargo, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Buy with Decreased Target from $14 to $10 on, Jan 4th, 2023.
Yanan has made no other calls on TSHA in the last 4 months.
There are 6 other peers that have a rating on TSHA. Out of the 6 peers that are also analyzing TSHA, 1 agrees with Yanan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $3 on, Wednesday, November 9th, 2022
These are the ratings of the 5 analyists that currently disagree with Yanan
- Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $20 on, Thursday, November 10th, 2022
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $16 on, Wednesday, November 9th, 2022
- Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $16 on, Wednesday, November 9th, 2022
- Whitney Ijem of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $16 on, Tuesday, November 8th, 2022
- Jack Allen of "Baird" Maintained at Buy with Decreased Target to $21 on, Wednesday, October 26th, 2022
Contributing Sources